The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Published:2019-01-24 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Li Yan,Huang Qingying,Zhou Yaoyao,He Meizhi,Chen Jianhong,Gao Yubo,Wang Xue

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Clinicopathologic and prognostic significance of programmed cell death ligand 1 expression in patients with non-medullary thyroid cancer: a systematic review and meta-analysis;Aghajani;Thyroid,2018

2. Immune characterization of the programmed death receptor pathway in high risk prostate cancer;Baas;Clin. Genitourin. Canc,2017

3. PD-L1 is highly expressed in Enzalutamide resistant prostate cancer;Bishop;Oncotarget,2015

4. “Fixed-effect versus random-effects models,”;Borenstein,2009

5. Phase I study of single-agent anti–programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and Validation of a Prognostic Model Based on Mitochondrial Genes in Prostate Cancer;Hormone and Metabolic Research;2024-06-13

2. Identification and validation of a novel anoikis‐related prognostic model for prostate cancer;Molecular Genetics & Genomic Medicine;2024-04

3. The Effect and Mechanism of Astragalus Polysaccharides on T Cells and Macrophages in Inhibiting Prostate Cancer;Biomedical Journal;2024-04

4. Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations;Expert Opinion on Biological Therapy;2024-01-31

5. DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology;International Journal of Molecular Sciences;2023-07-13